ArticleThe Canadian journal of urology2026
Endocrine stimulation in men with non-obstructive azoospermia and low serum testosterone prior to micro-TESE: hormonal response as a predictor of sperm retrieval.
Article in The Canadian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Micro-TESE in Non-Obstructive Azoospermia: Phenotype-Guided Hormonal Optimization and Testosterone Response-Prognostic Biomarker or Therapeutic Target?Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHormonal treatment and response as a predictor of sperm retrieval prior to microdissection testicular sperm extraction (micro-TESE) are not well established in the current literature. This study aimed to investigate the hormonal response as a predictor of sperm retrieval among men with nonobstructive azoospermia (NOA).
methodsSeventy-seven consecutive patients who had testosterone levels ≤ 14 nmol/L were treated medically with an aromatase inhibitor or recombinant human chorionic gonadotropin (rec-hCG) prior to micro-TESE and were included. Thirty-four (44.2%) had unexplained NOA (UNEX), 25 (32.5%) had Klinefelter syndrome (KS), 8 (10.4%) had a history of cryptorchidism (UDT), 4 (5.2%) had microdeletion of the Azoospermia factor C (AZFc), and 6 (7.8%) were treated previously with chemotherapy. Baseline and post-treatment serum hormonal levels were documented. Pre-op testosterone levels were entered into binary logistic regressions with age, Follicle-stimulating hormone (FSH), and Luteinizing hormone (LH) levels to test for significance with sperm retrieval. We then built logistic regression models to identify predictors of successful surgical sperm retrieval (SSR).
resultsForty-five patients (58%) had successful retrieval. In 32 patients (42%), no sperm was retrieved. Both the mean pre-op testosterone and the mean testosterone change between the two groups were significant (p = 0.02 and p = 0.011, respectively). Receiver operating characteristic (ROC) analysis demonstrated an area under the curve (AUC) of 0.785 (95%CI = 0.685-0.886, p < 0.001). The Youden index coefficient was calculated for KS and UNEX. The cut-off point for KS was established at 0.764 (sensitivity = 0.875, false positive rate [FPR] = 0.111), and 0.215 for UNEX (sensitivity = 0.438, FPR = 0.222). We also observed a correlation between age and SSR (p = 0.05). In KS patients, SSR was determined by pre-op testosterone levels irrespective of age.
conclusionPre-operative hormonal response is a predictor for SSR in NOA patients who were treated medically. This data may help during pre-operative counselling.
Indexed as
Identifiers
41800509What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.